Valassia Antigone "Noni" Theocharides, PharmD Candidate
Articles by Valassia Antigone "Noni" Theocharides, PharmD Candidate

The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future Directions
ByKevin Pang, PharmD,Sukeina Nasser, PharmD, CPh, PACS,Rachel Mintz, PharmD,Adina Kagan, PharmD Candidate,Valassia Antigone "Noni" Theocharides, PharmD Candidate,Jerry Ngo, PharmD The adjuvant therapy has demonstrated varied efficacy for patients.

Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
ByValassia Antigone "Noni" Theocharides, PharmD Candidate,Luisa Giannangelo, MBA, RPh,Jessie Modlin, PharmD, BCOP,Tesnim Shash, PharmD Candidate,Sukeina Nasser, PharmD, CPh, PACS Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.